These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2672043)

  • 1. [Aspects of trace analysis in drug control].
    Göber B
    Pharmazie; 1989 Jun; 44(6):381-3. PubMed ID: 2672043
    [No Abstract]   [Full Text] [Related]  

  • 2. Method development aspects for the quantitation of pharmaceutical compounds in human plasma with a matrix-assisted laser desorption/ionization source in the multiple reaction monitoring mode.
    Kovarik P; Grivet C; Bourgogne E; Hopfgartner G
    Rapid Commun Mass Spectrom; 2007; 21(6):911-9. PubMed ID: 17295425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitfalls and errors in drug monitoring: analytical aspects.
    Hassan FM; Pesce AJ; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):567-73. PubMed ID: 6664157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and therapeutic aspects of drug administration by rate-controlled drug delivery systems: steady-state pharmacology.
    Urquhart J
    Boll Chim Farm; 1984 Apr; 123(4):155-68. PubMed ID: 6383428
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of drugs in blood serum by mass spectrometry/mass spectrometry.
    Brotherton HO; Yost RA
    Anal Chem; 1983 Mar; 55(3):549-53. PubMed ID: 6846847
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of pharmacogenetic aspects in pediatric therapy].
    Scherber A; Seipelt H
    Padiatr Grenzgeb; 1986; 25(1):7-10. PubMed ID: 3960555
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical use of drug analysis].
    Penttilä O
    Duodecim; 1980; 96(5):347-51. PubMed ID: 7449679
    [No Abstract]   [Full Text] [Related]  

  • 8. Pitfalls and errors in drug monitoring: pharmacokinetic aspects.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):559-66. PubMed ID: 6664156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of drug level determination in therapy control].
    Endler AT; Gabl F
    Med Lab (Stuttg); 1982 Nov; 35(5):133-6. PubMed ID: 7177023
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of drug plasma levels. Is it clinically profitable?].
    González Martínez de Zárate JL
    An Esp Pediatr; 1986 Nov; 25(5):311-6. PubMed ID: 3813222
    [No Abstract]   [Full Text] [Related]  

  • 11. [Microthermic application on thin-layer and its use in the control of drugs. II. Evidence of azulene in pharmaceutical preparations].
    Kraus L; Stahl E; Gross H
    Cesk Farm; 1970 Oct; 19(8):310-1. PubMed ID: 5492516
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring of drug levels in blood: a challenge to the clinical biochemistry laboratory.
    Ford HC; Jellett LB; Maling TJ; Kappatos DC
    N Z Med J; 1980 May; 91(659):347-9. PubMed ID: 6930024
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic drug monitoring: an historical introduction.
    Marks V
    Am J Med Technol; 1983 Aug; 49(8):543-8. PubMed ID: 6367463
    [No Abstract]   [Full Text] [Related]  

  • 14. Extent of analyst bias in drug-assay results.
    Lesko LJ; Turo TT
    Am J Hosp Pharm; 1982 Mar; 39(3):486-7. PubMed ID: 6803589
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug binding to human alpha-1-acid glycoprotein in health and disease.
    Kremer JM; Wilting J; Janssen LH
    Pharmacol Rev; 1988 Mar; 40(1):1-47. PubMed ID: 3064105
    [No Abstract]   [Full Text] [Related]  

  • 16. Organization of a laboratory service for therapeutic drug monitoring.
    Walters MI; Speicher CE
    Clin Lab Med; 1981 Sep; 1(3):439-50. PubMed ID: 7346214
    [No Abstract]   [Full Text] [Related]  

  • 17. Setting up a laboratory for therapeutic drug monitoring.
    Kalman SM
    Hosp Formul; 1982 Apr; 17(4):568-70, 573. PubMed ID: 10317192
    [No Abstract]   [Full Text] [Related]  

  • 18. [Measurements of plasma drug concentration as a guide in drug therapy].
    Bircher J
    Ther Umsch; 1980 Oct; 37(10):918-23. PubMed ID: 7455956
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug level determination for optimization of drug therapy. Practical significance and new trends].
    Vozeh S
    Schweiz Rundsch Med Prax; 1984 Dec; 73(49):1505-6. PubMed ID: 6515217
    [No Abstract]   [Full Text] [Related]  

  • 20. [Some aspects on drug safety control].
    Pekkarienen A
    Nord Med; 1967 Nov; 78(47):1539-42. PubMed ID: 6075273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.